WallStSmart
TRVI

Trevi Therapeutics Inc

NASDAQ: TRVI · HEALTHCARE · BIOTECHNOLOGY

$13.82
-0.14% today

Updated 2026-04-29

Market cap
$1.96B
P/E ratio
P/S ratio
EPS (TTM)
$-0.32
Dividend yield
52W range
$5 – $16
Volume
1.5M

Trevi Therapeutics Inc (TRVI) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+17.3%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+45.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+3.0%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+10.9%
2026-03-25
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-25$-0.06+39.1%$10.64$11.80+10.9%
2025-11-13$-0.08+20.0%$11.85$11.37-4.1%
2025-08-07$-0.09+10.0%$7.27$7.42+2.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.10$-0.06+39.1%
2025-09-30$-0.10$-0.08+20.0%
2025-06-30$-0.10$-0.09+10.0%
2025-03-31$-0.09$-0.09+0.0%
2024-12-31$-0.12$-0.11+6.1%$146000.00-17.0%
2024-09-30$-0.12$-0.13-8.3%
2024-06-30$-0.11$-0.12-9.1%
2024-03-31$-0.09$-0.11-22.2%
2023-12-31$-0.09$-0.08+11.1%$176000.00
2023-09-30$-0.09$-0.08+11.1%
2023-06-30$-0.08$-0.07+12.5%
2023-03-31$-0.07$-0.06+14.3%

Frequently asked questions

Has Trevi Therapeutics Inc beaten earnings estimates?
Trevi Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +17.3% over the last 4 quarters.
How does TRVI stock react to earnings?
TRVI stock has moved an average of +3.0% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.